Does nicotine influence cytokine profile and subsequent cell cycling/apoptotic responses in inflammatory bowel disease?

This publication has 69 references indexed in Scilit:

• Chronic nicotine stimulation modulates the immune response of mucosal T cells to Th1-dominant pattern via nAChR by upregulation of Th1-specific transcriptional factor
  Neuroscience Letters, 2008
• Unravelling the pathogenesis of inflammatory bowel disease
  Nature, 2007
• The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease
  Clinical and Experimental Immunology, 2007
• Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-κB phosphorylation and nuclear factor-κB transcriptional activity through nicotinic acetylcholine receptor α7
  Clinical and Experimental Immunology, 2006
• IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
  Journal of Clinical Investigation, 2006
• α7 Nicotinic Acetylcholine Receptor Stimulation Inhibits Lipopolysaccharide-Induced Interleukin-18 and -12 Production in Monocytes
  Journal of Pharmacological Sciences, 2006
• Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1–dependent pathway
  The Journal of Experimental Medicine, 2005
• Inflammatory Bowel Disease and Smoking
  Inflammatory Bowel Diseases, 2004
• Nicotine increases oxidative stress, activates NF-κB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis
  Chemico-Biological Interactions, 2003
• Transdermal Nicotine for Active Ulcerative Colitis
  New England Journal of Medicine, 1994